Related Experiment Video
Updated: Jun 25, 2026

07:45
Quantifying Intermembrane Distances with Serial Image Dilations
Published on: September 28, 2018
6.4K
Imagenetics for Precision Medicine in Dilated Cardiomyopathy
Alexios S Antonopoulos1, Anastasia Xintarakou1, Alexandros Protonotarios2,3
11st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Greece (A.S.A., A.X., G.L., A.M., K.T., C.V.).
Circulation. Genomic and Precision Medicine
|February 28, 2024
Summary
Genetic dilated cardiomyopathy (DCM) requires personalized risk assessment. Combining advanced imaging and genetics (imagenetics) can improve genotype-phenotype correlations and guide precision medicine for DCM patients.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a common nonischemic heart muscle disorder linked to heart failure, arrhythmias, and sudden cardiac death.
- Genetic DCM presents variably, necessitating tailored risk stratification and sudden cardiac death prevention strategies.
- Advances in cardiogenetics and cardiac imaging have improved understanding of DCM mechanisms, genetic architecture, and phenotypic spectrum.
Purpose of the Study:
- To review current literature on the role of genetics and imaging in DCM.
- To summarize established and emerging data on genotype-phenotype associations in DCM.
- To highlight the potential of combining imaging and genetics (imagenetics) for precision medicine in DCM.
Main Methods:
- Literature review of existing research on genetics, imaging, and DCM.
- Analysis of genotype-phenotype correlations in various DCM subtypes.
- Exploration of the emerging field of imagenetics in DCM.
Main Results:
- Genetics and imaging have advanced DCM recognition and understanding of disease mechanisms.
- Established genotype-phenotype associations exist for specific DCM subtypes (e.g., DSP, FLNC), but are often elusive.
- Imagenetics holds promise for improving genotype-phenotype correlations and clinical decision-making.
Conclusions:
- Genetics and imaging are crucial for understanding DCM, but genotype-phenotype correlations remain challenging.
- Further research combining imaging and genetics is needed to advance precision medicine for DCM patients.
- Identifying patients at risk for progression or remission requires continued investigation into disease mechanisms.

